Cargando…

Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases

BACKGROUND: Minimally invasive specific biomarkers of neurodegenerative diseases (NDs) would facilitate patient selection and disease progression monitoring. We describe the assessment of circulating brain-enriched microRNAs as potential biomarkers for Alzheimer’s disease (AD), frontotemporal dement...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheinerman, Kira S., Toledo, Jon B., Tsivinsky, Vladimir G., Irwin, David, Grossman, Murray, Weintraub, Daniel, Hurtig, Howard I., Chen-Plotkin, Alice, Wolk, David A., McCluskey, Leo F., Elman, Lauren B., Trojanowski, John Q., Umansky, Samuil R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679501/ https://www.ncbi.nlm.nih.gov/pubmed/29121998 http://dx.doi.org/10.1186/s13195-017-0316-0

Ejemplares similares

Analysis of organ-enriched microRNAs in plasma as an approach to development of Universal Screening Test: feasibility study
por: Sheinerman, Kira S, et al.
Publicado: (2013)

Early detection of neurodegenerative diseases: Circulating brain-enriched microRNA
por: Sheinerman, Kira S., et al.
Publicado: (2013)

Brain-enriched microRNAs circulating in plasma as novel biomarkers for Rett syndrome
por: Sheinerman, Kira, et al.
Publicado: (2019)

Age- and sex-dependent changes in levels of circulating brain-enriched microRNAs during normal aging
por: Sheinerman, Kira, et al.
Publicado: (2018)

Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies
por: Sheinerman, Kira S., et al.
Publicado: (2013)

Plasma microRNA biomarkers for detection of mild cognitive impairment: Biomarker Validation Study
por: Sheinerman, Kira S., et al.
Publicado: (2013)

Plasma microRNA biomarkers for detection of mild cognitive impairment
por: Sheinerman, Kira S., et al.
Publicado: (2012)

Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology
por: Portelius, Erik, et al.
Publicado: (2018)

Elevated CSF GAP-43 is Alzheimer’s disease specific and associated with tau and amyloid pathology
por: Sandelius, Åsa, et al.
Publicado: (2018)

Analytical Validation of a Novel MicroRNA Panel for Risk Stratification of Cognitive Impairment
por: Kunwar, Arzu, et al.
Publicado: (2023)

Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis
por: Brettschneider, Johannes, et al.
Publicado: (2012)

Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated
por: Robinson, John L, et al.
Publicado: (2023)

Aging and aging-associated diseases: a microRNA-based endocrine regulation hypothesis
por: Umansky, Samuil
Publicado: (2018)

Plasma phosphorylated tau181 predicts cognitive and functional decline
por: Tropea, Thomas F., et al.
Publicado: (2022)

Evaluation of long-term COVID-19
por: Kiefer, Michael C., et al.
Publicado: (2021)

PolyQ Repeat Expansions in ATXN2 Associated with ALS Are CAA Interrupted Repeats
por: Yu, Zhenming, et al.
Publicado: (2011)

Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body disease
por: Cousins, Katheryn A. Q., et al.
Publicado: (2023)

Characterization of Parkinson’s disease using blood-based biomarkers: A multicohort proteomic analysis
por: Posavi, Marijan, et al.
Publicado: (2019)

Decision-Making Deficits Associated with Amyloidosis in Lewy Body Disorders
por: Spotorno, Nicola, et al.
Publicado: (2017)

Topography of FUS pathology distinguishes late-onset BIBD from aFTLD-U
por: Lee, Edward B, et al.
Publicado: (2013)

Tau pathology associates with in vivo cortical thinning in Lewy body disorders
por: Spotorno, Nicola, et al.
Publicado: (2020)

Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease
por: Irwin, David J., et al.
Publicado: (2013)

Linear Associations between Clinically Assessed Upper Motor Neuron Disease and Diffusion Tensor Imaging Metrics in Amyotrophic Lateral Sclerosis
por: Woo, John H., et al.
Publicado: (2014)

An Alzheimer’s Disease-Derived Biomarker Signature Identifies Parkinson’s Disease Patients with Dementia
por: Berlyand, Yosef, et al.
Publicado: (2016)

The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders
por: Irwin, David J., et al.
Publicado: (2018)

Age-Correlated Gene Expression in Normal and Neurodegenerative Human Brain Tissues
por: Cao, Kajia, et al.
Publicado: (2010)

Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle counting
por: Blömeke, Lara, et al.
Publicado: (2022)

Relationship between Plasma Analytes and SPARE-AD Defined Brain Atrophy Patterns in ADNI
por: Toledo, Jon B., et al.
Publicado: (2013)

Signature laminar distributions of pathology in frontotemporal lobar degeneration
por: Ohm, Daniel T., et al.
Publicado: (2022)

Empiric Methods to Account for Pre-analytical Variability in Digital Histopathology in Frontotemporal Lobar Degeneration
por: Giannini, Lucia A. A., et al.
Publicado: (2019)

Factors Influencing Performance of Cardiopulmonary Resuscitation (CPR) by Foundation Year 1 Hospital Doctors
por: Sayee, Nicole, et al.
Publicado: (2012)

Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration
por: Cervantes González, Alba, et al.
Publicado: (2022)

Selection for Protein Stability Enriches for Epistatic Interactions
por: Posfai, Anna, et al.
Publicado: (2018)

Divergent Histopathological Networks of Frontotemporal Degeneration Proteinopathy Subytpes
por: Chen, Min, et al.
Publicado: (2022)

Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia
por: Akhtar, Rizwan S., et al.
Publicado: (2017)

Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies
por: Young, Alexandra L, et al.
Publicado: (2023)

Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies
por: Young, Alexandra L, et al.
Publicado: (2023)

Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases
por: McAlary, Luke, et al.
Publicado: (2019)

Parking : manual de diseño ambiental
por: McCluskey, Jim
Publicado: (1990)

El diseño de vías urbanas
por: McCluskey, Jim
Publicado: (1985)

Cannot write session to /tmp/vufind_sessions/sess_lav545vmnhn135g2k5176k07f9